StemGen, Inc. (SGNI) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
800 TOWN AND COUNTRY BLVD. HOUSTON, TX 77024 |
| State of Incorp. | DE |
| Fiscal Year End | June 30 |
| Industry (SIC) | 6799 - Investors, Not Elsewhere Classified (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 6/30/2015 | 6/30/2014 | 6/30/2013 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 80 | 840 | |||
| Cash and cash equivalent | 80 | 840 | |||
| Total current assets: | 80 | 840 | |||
| Noncurrent Assets | |||||
| TOTAL ASSETS: | 80 | 840 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities, including: | 137,542 | ||||
| Interest and dividends payable | 90,822 | ||||
| Accounts payable | 46,720 | ||||
| Other undisclosed accounts payable and accrued liabilities | |||||
| Debt | |||||
| Deferred compensation liability | |||||
| Other undisclosed current liabilities | 176,638 | ||||
| Total current liabilities: | 314,180 | ||||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation | |||||
| Long-term debt, excluding current maturities | |||||
| Other undisclosed noncurrent liabilities | |||||
| Total noncurrent liabilities: | |||||
| Total liabilities: | 314,180 | ||||
| Equity | |||||
| Equity, attributable to parent | 80 | (313,340) | |||
| Preferred stock | |||||
| Common stock | 101,839 | 1,839 | |||
| Common stock, value, subscriptions | ✕ | ✕ | |||
| Additional paid in capital | 722,783 | 525,783 | |||
| Accumulated deficit | (824,542) | (840,962) | |||
| Total equity: | 80 | (313,340) | |||
| TOTAL LIABILITIES AND EQUITY: | 80 | 840 | |||
Income Statement (P&L) (USD)
| 6/30/2015 | 6/30/2014 | 6/30/2013 | ||
|---|---|---|---|---|
| Operating expenses | (51,183) | (60,202) | ||
| Operating loss: | (51,183) | (60,202) | ||
| Nonoperating income | 67,603 | 32,500 | ||
| Gain on contract termination | 32,500 | |||
| Debt instrument, convertible, beneficial conversion feature | ||||
| Interest and debt expense | (39,617) | (124,605) | ||
| Loss from continuing operations: | (23,197) | (152,307) | ||
| Loss before gain (loss) on sale of properties: | (23,197) | (152,307) | ||
| Other undisclosed net income | 39,617 | 63,888 | ||
| Net income (loss): | 16,420 | (88,419) | ||
| Other undisclosed net loss attributable to parent | ||||
| Net income (loss) available to common stockholders, diluted: | 16,420 | (88,419) | ||
Comprehensive Income (USD)
| 6/30/2015 | 6/30/2014 | 6/30/2013 | ||
|---|---|---|---|---|
| Net income (loss): | 16,420 | (88,419) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 16,420 | (88,419) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.